Event Details

ANZBMS Webinar: Optimising Osteoporosis Management – Treatment Sequence and Timing Matter

Date:
25 Aug 2025 at 6:00 PM to 7:00 PM
Location:
Online
Host:
Australian and New Zealand Bone and Mineral Society

This presentation will focus on:

  1. Optimal treatment sequences in patients with severe osteoporosis
  2. Timing of treatment sequences to optimise increases in BMD
  3. Evidence for combined anabolic and antiresorptive therapy transitions
  4. Individualising treatment approaches to treat to target

Professor Peter Ebeling is Head of the Department of Medicine and Head of the School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University. He is a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS), which aims to advance health and medical research in Australia and ensure its application benefits all Australians.

In 2023, Professor Ebeling was elected a Fellow of the Royal College of Physicians (London). He was the inaugural Director of the Australian Institute of Musculoskeletal Science. In 2015, he was appointed an Officer of the Order of Australia (AO) for distinguished service to the field of bone health.

His research interests include musculoskeletal health and disease, the public health implications of vitamin D, post-transplantation osteoporosis, and osteoporosis in men.

Professor Ebeling has served as Associate Editor of JBMR®, Editor of Clinical Endocrinology (Oxf), and Editor-in-Chief of Bone Reports and JBMR® Plus. He is currently Editor-in-Chief of Bone and serves on the Editorial Board of Osteoporosis International. He is a Past President of the American Society for Bone and Mineral Research, Chair of the Board of Healthy Bones Australia, a Board Member of the International Osteoporosis Foundation, and a Past President of both the Endocrine Society of Australia and ANZBMS. He also served on the National Health and Medical Research Council’s Research Committee from 2015 to 2018.

From 2019 to 2024, he published 156 peer-reviewed papers, including in Journal of Clinical Investigation, Journal of Clinical Oncology, The Lancet Diabetes & Endocrinology, and JBMR®. Overall, he has authored over 575 peer-reviewed publications, with more than 40,000 citations and an h-index of 98, including papers published in The New England Journal of Medicine, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation, and Science.

Professor Ebeling also teaches and mentors medical students, supervises research higher degree students, and trains advanced physician trainees in endocrinology.

Register

Close overlay